Aclaris Therapeutics logo
Aclaris Therapeutics ACRS
$ 4.28 8.08%

Quarterly report 2024-Q3
added 11-06-2024

report update icon

Aclaris Therapeutics Cost of Revenue 2011-2024 | ACRS

Annual Cost of Revenue Aclaris Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
3.42 M 4.02 M 4.71 M 5.13 M 4.06 M 4.33 M 1.21 M - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
5.13 M 1.21 M 3.84 M

Quarterly Cost of Revenue Aclaris Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
654 K 624 K 809 K - 848 K 1.04 M 808 K - 923 K 1.07 M 1.16 M - 1.1 M 1.26 M 1.2 M - 1.19 M 1.39 M 1.27 M - 826 K 994 K 1.21 M - 1.07 M 1.18 M 967 K - 453 K - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
1.39 M 453 K 1 M